Table 3 Parameter estimates predicting overexpression from histology
From: Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways
OR | 95% CI | P | Wald chi-square | ||
|---|---|---|---|---|---|
BCRP | Carcinoma and serous | 2.21 | .88-5.58 | 0.09 | 8.39, p = .039 |
Clear cell | 2.2 | .49-9.94 | 0.3 | ||
Endometriod | 0.735 | .22-2.41 | 0.61 | ||
ER | Carcinoma and serous | 1.39 | .63-3.05 | 0.42 | 7.76, p = .051 |
Clear Cell | 0.26 | .06-1.09 | 0.07 | ||
Endometriod | 1.55 | .54-4.46 | 0.42 | ||
MGMT | Carcinoma and serous | 1.64 | .46-5.81 | 0.48 | 18.57, p < .001 |
Clear cell | 0.2 | .04-.86 | 0.03 | ||
Endometriod | 1.56 | .24-10.14 | 0.64 | ||
PTEN | Carcinoma and serous | 1.19 | .54-2.61 | 0.67 | 7.01, p = .071 |
Clear cell | 0.59 | .19-1.85 | 0.36 | ||
Endometriod | 0.49 | .17-1.41 | 0.18 | ||
RRM1 | Carcinoma and serous | 0.67 | .31-1.46 | 0.32 | 13.06, p = .005 |
Clear cell | 0.13 | .03-.52 | 0.004 | ||
Endometriod | 0.25 | .08-.78 | 0.017 |